|
UTP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.371890E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.618300E-04 |
| Normal-vs-Stage2 |
5.404100E-02 |
| Normal-vs-Stage3 |
6.156600E-03 |
| Normal-vs-Stage4 |
2.758000E-02 |
| Stage1-vs-Stage2 |
6.887000E-01 |
| Stage1-vs-Stage3 |
9.761400E-01 |
| Stage1-vs-Stage4 |
8.739400E-01 |
| Stage2-vs-Stage3 |
6.456200E-01 |
| Stage2-vs-Stage4 |
8.694000E-01 |
| Stage3-vs-Stage4 |
8.262400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.184500E-04 |
| Normal-vs-AfricanAmerican |
1.042490E-03 |
| Normal-vs-Asian |
3.454400E-01 |
| Caucasian-vs-AfricanAmerican |
7.673000E-01 |
| Caucasian-vs-Asian |
9.666600E-01 |
| AfricanAmerican-vs-Asian |
8.658400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.64039999999944E-05 |
| Normal-vs-Female |
1.471930E-02 |
| Male-vs-Female |
1.766630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.052400E-02 |
| Normal-vs-Extreme_Weight |
3.200900E-03 |
| Normal-vs-Obese |
1.044010E-02 |
| Normal-vs-Extreme_Obese |
4.629200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.215400E-01 |
| Normal_Weight-vs-Obese |
8.199800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.128400E-01 |
| Extreme_Weight-vs-Obese |
5.987800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.935600E-01 |
| Obese-vs-Extreme_Obese |
5.821600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.637600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.54720000000009E-05 |
| Normal-vs-Age(61-80Yrs) |
4.281900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.815550E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.081030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.610800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.060240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.627600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.599600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.84039999995278E-06 |
| Normal-VS-Type2 PRCC |
4.563600E-02 |
| Normal-VS-KIRP CIMP |
4.761800E-01 |
| Normal-VS-Unclassified PRCC |
1.518780E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.997400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.880100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.582600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.419200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.632400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.336250E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14070000001298E-06 |
| Normal-vs-N1 |
2.204600E-01 |
| Normal-vs-N2 |
2.374700E-04 |
| N0-vs-N1 |
3.796000E-03 |
| N0-vs-N2 |
2.801000E-01 |
| N1-vs-N2 |
2.356300E-02 |
|
|
